Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials

By BY PAM BELLUCK from NYT Health https://ift.tt/P3RaqZM

A second booster helped protect older people from Omicron infection, but waned quickly, an Israeli study says.

By BY EMILY ANTHES from NYT Health https://ift.tt/4iGE6sm

Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug

By BY PAM BELLUCK from NYT Health https://ift.tt/w4rPJyW

The F.D.A. suspends use of a Glaxo antibody drug in the U.S. as an Omicron subvariant spreads.

By BY ADEEL HASSAN from NYT Health https://ift.tt/cHEVJZ2

A second booster helped protect older people from Omicron infection, but waned quickly, an Israeli study says.

By BY EMILY ANTHES from NYT Health https://ift.tt/VwAocG9

The C.D.C. will undergo a comprehensive re-evaluation, the agency’s director said.

By BY RONI CARYN RABIN from NYT Health https://ift.tt/HbFTkdq

Mass distribution of coronavirus tests may have helped blunt the Delta surge in two Michigan cities, a study suggests.

By BY EMILY ANTHES from NYT Health https://ift.tt/kayOwiT